Vol. 41 No. 4 (2024): Agosto
Clinical Case

Primary cutaneous mucormycosis due to Rhizopus arrhizus in an immunocompromised patient. About a case report.

PDF (Español (España))
  • Camila Diez de Medina,
  • Andrés Soto,
  • Pablo Villegas,
  • Cecilia Jeraldo

Published 2024-09-04

Keywords

How to Cite

1.
Diez de Medina C, Soto A, Villegas P, Jeraldo C. Primary cutaneous mucormycosis due to Rhizopus arrhizus in an immunocompromised patient. About a case report. Rev. Chilena. Infectol. [Internet]. 2024 Sep. 4 [cited 2026 Feb. 13];41(4). Available from: https://revinf.cl/index.php/revinf/article/view/2094

Copyright (c) 2024 Camila Diez de Medina, Andrés Soto, Pablo Villegas, Cecilia Jeraldo

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Mucormycosis corresponds to a potentially fatal invasive fungal disease that has an increasing incidence, mainly in immunocompromised onco-hematological patients and stem-cell transplant recipients. Skin involvement being one of its clinical presentations. We report the case of a 21-year-old patient, diagnosed with acute lymphoblastic leukemia, who developed primary cutaneous mucormycosis caused by Rhizopus arrhizus, confirmed by molecular methods and histology, and who evolved favorably after a large surgical resection and antifungal therapy based on to liposomal amphotericin B and isavuconazole.

PDF (Español (España))